Aurora Cannabis (NASDAQ:ACB - Get Free Report) issued its quarterly earnings results on Wednesday. The company reported $0.06 earnings per share for the quarter, beating analysts' consensus estimates of ($0.09) by $0.15, Zacks reports. Aurora Cannabis had a net margin of 0.42% and a return on equity of 0.59%.
Aurora Cannabis Trading Down 3.5 %
Shares of ACB stock traded down $0.22 during trading hours on Friday, reaching $6.03. 8,729,844 shares of the stock traded hands, compared to its average volume of 5,163,835. The company has a quick ratio of 1.88, a current ratio of 3.30 and a debt-to-equity ratio of 0.07. The firm has a market capitalization of $330.81 million, a PE ratio of 120.62 and a beta of 1.84. Aurora Cannabis has a 1-year low of $2.84 and a 1-year high of $9.35. The business has a fifty day moving average price of $4.27 and a 200 day moving average price of $5.16.
Wall Street Analysts Forecast Growth
A number of brokerages recently weighed in on ACB. Atb Cap Markets upgraded shares of Aurora Cannabis from a "hold" rating to a "strong-buy" rating in a report on Wednesday. TD Securities raised Aurora Cannabis to a "strong-buy" rating in a research note on Thursday, December 12th. Finally, TD Cowen began coverage on Aurora Cannabis in a research report on Wednesday, December 11th. They set a "buy" rating on the stock.
Get Our Latest Stock Report on ACB
About Aurora Cannabis
(
Get Free Report)
Aurora Cannabis Inc, together with its subsidiaries, produces, distributes, and sells cannabis and cannabis-derivative products in Canada and internationally. It operates through three segments: Canadian Cannabis, European Cannabis, and Plant Propagation. The company produces, distributes, and sells medical and consumer cannabis products in Canada.
Read More
Before you consider Aurora Cannabis, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Aurora Cannabis wasn't on the list.
While Aurora Cannabis currently has a "Strong Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know? MarketBeat just compiled its list of the twelve stocks that corporate insiders are abandoning. Complete the form below to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
